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PREVIOUS work (Pikovski and Witz, 1961) on soluble antigens of normial
tissues and mammary tumours from mice of the RIII strain showed the presence
of specific antigens of protein nature in the liver and kidney. There was also all
indication-though no definite proof-that a specific antigen of mammarv glands
was lacking in mammary tumours.
It was also shown that in the transplantable and spontaneous mammary
tumours of the RIII strain, a soluble antigen of protein nature was present in a
much higher concentration than in the normal tissues of mice of this strain.
The work of other investigators, employing various serological methods in
dealing with different cell components and protein fractions, also indicated quanti-
tative and qualitative differences in the antigens of tumours as compared to the
corresponding normal tissues of humans and animals.
Most of this work has been well reviewed (Hauschka, 1952; Zilber, 1958:
Southam, 1960); we shall refer mainly to studies on soluble antigens.
The loss ofunsoluble as well as partly soluble specific tissue antigens in tumnouns
originating in these tissues was demonstrated by different serological methods
(Weiler, 1956; Nairn et al., 1960).
Increase as well as decrease in some soluble antigens of mouse tumours were
demonstrated by Easty and Ambrose (1957), Abramoff et al., (1959), Plescia et
al., (1959) and Levina (1959).
Similar changes were also reported in soluble antigens of human cancers by
Witebsky et al. (1956), Gorodilova and Shershulskaia (1959) and Zilber (1958):
and in human leukemic cells by Seligmann, Grabar and Bernard (1959).
The first part ofthe present study deals with a specific antigen ofthe mammarx
glands lacking in mammary tumours, the second with the evaluation of the
presence of an antigen in a transplantable mammary carcinoma and in normal
tissues, serum and urine of tumour-bearing mice of the same strain.
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MATERIALS AND METHODS
The mice in these experiments belonged to the RIII strain (Syn: Paris R3).
The subline used was inbred by us for 30 generations. The strain was highly
cancerous for at least 16 generations, but then the cancer incidence gradually
began to decrease, being very low at present. The strain of the transplantable
mammary carcinoma( MMC1A) described previously (Pikovski and Schlesinger,
1955 and 1959) started from a spontaneous tumour which occurred in the 8th
generation, at the time when the strain showed a high mammary tumour incidence,
and was since transplanted exclusively in this strain. The tumours used, were
from the 100-150th passages.
Tissue extracts
Freshly excised normal organs, or carefully selected non-haemorrhagic parts
of tumours were finely cut up, distilled water was added, the mash lyophylized
and kept in closed containers over silica gel at 4° C. For the preparation of
extracts, the dry tissues were powdered, saline added to necessary concentration;
the suspension was then homogenized and centrifuged at 18,000 x g. The
supernate was distributed 1-5 c.c. in test tubes, kept at -20° C. and defrosted
shortly before use either for immunization, or for precipitation tests. The con-
centration of the tissue extracts compared on one plate was brought to a
similar protein content as estimated by the Biuret- or Micro Kjeldahl method.
The protein content ofdry tumour and of the mixture ofnormal tissues was shown
to be approximately equal, and amounted to half of their weight; whereas the
protein content of the dry mammary gland was 0-25 of its weight.
The highly concentrated extracts used in some experiments were prepared
by lyophylizing the measured amounts of a 40 mg./ml. extract and redissolving
the dry powder in a necessary amount of water.
The colostrum was obtained from the stomachs of one day old mice, homo-
genized with saline, centrifuged, the fat taken off and the supernate used.
The urine was collected for 17-18 hours from each mouse separately, with
addition of streptomycin and penicillin.
The antisera were produced in rabbits. Suitable antisera against MMC1A
were obtained by 3 intramuscular injections, twice weekly, of 2 ml. tissue extract
in Freund's adjuvant. This was followed a week later by an intraperitoneal
booster injection of 5 ml. ofextract. Ten days after the booster, 2-3 ml. ofblood
were obtained from the ear for a test and if the serum was found satisfactory, the
rabbit was bled from the heart 4-6 days later.
However, this method proved unsuitable for the demonstration of the specific
mammary gland antigen. For this purpose good antisera were obtained by 2-3
intradermal injections into the foot pads of 0-2 c.c. of a mammary gland extract
(40 mg./ml.) in Freund's adjuvant.
Precipitation tests
The double diffusion gel precipitation method of Ouchterlony was used for
demonstration of antigens.
The method ofBjorklund (1952) was used for absorption with soluble antigens
by incorporating tissue extracts of various concentrations into the agar.
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Tests on the nature of the antigen
(1) Commercial preparations of enzymes were incubated with the tissue
extracts in a 1: 1 ratio, as follows
Incubation
Duration Temperature
Enzyme Concentration pH (hr.) °C.
Trypsin . 10mg./ml. . 76 20 37
Papain . . 10mg./ml. 7 0 20 37
Ribonuclease (protease free) 750 /ug./ml. 72 . 1 37
Hyaluronidase . . 2 mg./ml. 70 4 37
(with shaking)
(2) Periodate (NaIO4): 0-04M solution was mixed with the tumour extract
in a 1: 1 ratio and kept at pH 7, at room temperature for 1 hour.
(3) Precipitation of proteins with Rivanol (6-9 diamino 2 ethoxyacridine
lactate) was carried out according to Saifer and Lipkin (1959). The supernate
was used.
RESULTS
I. Antigens of mammary glands
Since the epithelium of mammary glands is only a part of the tissue taken for
immunization, it was likely that a specific antigen-if present in our extracts-
was in low concentration, moreover it could be also a weak antigen. Methods to
obtain antibodies suitable for demonstration of this antigen were sought. It was
shown that antisera obtained by intradermal injections into the foot pads of
small amounts ofmammary glands extract in adjuvant, revealed in the mammary
glands 2-3 antigens common to a mixture of normal tissues (liver, kidney and
spleen), and one antigen not shared with these tissues. This antigen produced
a very straight, sharp, conspicuous band (Fig. 1). This band alone was still
apparent after absorption with the extracts of mixed normal kidney, liver and
spleen (Fig. 2). It was also shown that extracts of normal tissues tested in
concentrations of 20-160 mg./ml. against the same antiserum, gave 2-3 bands
common with those produced by mammary glands, however the straight band
was never apparent.
It was further shown that extracts of mammary tumours, equally tested in
concentrations from 20-160 mg./ml. against the sa-me antiserum, gave at least
4 bands, but the straight, conspicuous band of the mammary glands was not
produced by these extracts either (Fig. 3).
The absorption of the anti-mammary gland serum with tumour extracts did
not remove the antibodies against the antigen producing the conspicuous straight
line (Fig. 4).
Since the mammary glands were removed from pregnant mice at about 10-15
days of pregnancy, there was a possibility that the conspicuous line may have
been due to an antigen of the colostrum. However, it could be demonstrated
that, although the colostrum gave 4-5 bands with the antiserum against the
mammary glands, the conspicuous band ofthe mammary gland was not produced
by the colostrum.
Thus a tissue specific antigen was demonstrated in the mammary glands,
this antigen was lacking in the mammary tumours. Preliminary tests on its
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nature showed that it was destroyed by boiling and proteolytic enzymes, and that
after the precipitation of proteins by Rivanol it remained in the supernatant
fraction. It is therefore a protein, which behaves like a serum globulin.
II. Antigens of mammary tumours
Tests with antisera against MMC1A, obtained from several rabbits, revealed
that 4-6 bands were produced by extracts of MMC1A. One band was of special
interest as it always had a characteristic density, shape and position, and was
invariably produced by every individual tumour sample of the MMCIA, or by
pools derived from different passages of this tumour (Fig. 5, 9, 12). Extracts
of spontaneous mammary tumours of the RIII and C3H strain equally produced
this conspicuous band.
After absorption with an extract of 20 mg./ml. ofmixed normal tissues (kidney,
liver, spleen and mammary glands) 2 bands were still obtained with tumour
extracts. Absorption with extracts of 40-80 mg./ml. removed antibodies against
all antigens, except one which produced the strong band, slightly curved to the
serum well (Fig. 6). Absorption by each of these antigens separately did also
not affect the appearance of this sharp conspicuous band.
Preliminary tests on the nature of the antigen producing the conspicuous
band showed that, while it was not affected by either hyaluronidase, ribonuclease
or sodium periodate, it was destroyed by boiling and by proteolytic enzymes
(papain, trypsin). After precipitation of proteins by Rivanol it remained in
the supernatant. Therefore, similarly to the mammary glands antigen, this was a
protein behaving like a serum globulin. Although the band was not produced
by extracts of normal tissues in concentra.tions equal to those of tumours, it was,
however, not specific to tumour tissue. The use of extracts of normal tissues
in a concentration of 160 mg./ml. revealed a band identical with that produced
by 5 mg./ml. extracts of tumours, though situated nearer to the antigen well,
indicating roughly that in normal tissues this antigen was also present but in
a concentration at least 30 times lower than in the tumour. This approximate
proportion was confirmed by further experiments with serial dilutions of tumour
and normal tissue extracts. Undiluted antiserum was used against twofold dilu-
tions of tissue extracts. These were all compared with an extract of MMC1A
at 10 mg./ml.
The use of this technique demonstrated that a visible band was still produced
by extracts of MMC1A in a concentration of 0-6 mg./ml. (300 ,tg. protein) (Fig.
9) as compared to 20 mg./ml., the lowest concentration, where a similar band
was produced by extracts of mixed normal tissues. Titration of each normal
organ separately showed that the band was still produced by 20 mg./ml. extracts
of liver, kidney, mammary glands and lymph glands, though not less than 80
mg./ml. were required to obtain a band by extracts of spleen.
A different picture was observed when the amount of the MMC1A antigen
in normal organs of tumour-bearing mice was investigated, this was shown to
be considerably higher than in the organs of normal mice. At the concentration
of 5 mg./ml., a visible band was still produced by the extracts of mixed normal
tissues, or by separate extracts of kidney, liver, and lymph glands from tumour-
bearing mice, as compared to 20 mg./ml. of corresponding tissues from normal
mice. However, the spleen extracts from tumour-bearing mice produced a
visible band only in concentrations beginning from 20 mg./ml., as compared to
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80 mg./ml. of normal spleen extracts (Table 1). It was thus indicated that the
concentration ofthis antigen is approximatelv 4 times higher in each ofthe organs
of tumour-bearing mice as compared with the corresponding organs of normal
animals.
TABLE L.-Lowest Concentration ofExtracts ofLyophylized Tissues
(mg./ml.) where the MMClA Band was still Visible
Mammary Lymph
MMC1A Liver Kidney glands Spleen glands
Normal mice . 20 20 . 20 80 20
Tumour-bearing mice 06 5 . 5 . 5 20 5
This proportion was found to be similar in sera. In pools of sera from normal
mice and those bearing mammary tumours (MMCIA) of differcnt passages, an
antigen was demonstrated producing a band identical with the conspicuous band
of extracts of MMCIA. The concentration of this antigen in sera of tumour-
b)earing mice was, however, 4-8 times highel than in sera of normal mice.
The different nature ofthe mammary gland antigen and the mammary tumour
antigen was revealed by the following experiment. The combination of wells as
designed by Abelev (1960) was used to compare antigens of two antigen-antibody
systems, where common antigens would produce parallel bands, while bands
produced by different antigens would cross. Comparing the bands produced by
the mammary glands and by the mammary tumours with their corresponding
EXPLANATION OF PLATES
FIG. 1. A. Anti-mammarygland serum. B. Mammarygland. c. Mixture ofliver, kidneyand
spleen.
FIG. 2.-A, B, c. Same as Fig. 1. Absorption with mixture of liver, kidney and spleen.
FIG. 3.-A. Anti-mammary gland serum. B. Mammary gland. c. Mammary tumour
(MMCIA).
FIG. 4.-A, B, C. Same as in Fig. 3. Absorption with mammary tumour (MMC1A).
FIG. 5.-A. Anti-mammary tumour (MMCIA) serum. B. MMC1A. c. Mixture of liver,
kidney, spleen and mammary gland.
FIG. 6.-A, B, C. Same as in Fig. 5. Absorption with mixture of liver, kidney, spleen and
mammary gland.
FIG. 7.-A. Mammary tumour (MMCIA). B. Mammary gland. c. Anti-mammary tumour
(MMC1A) serum. D. Anti-mammary gland serum.
FIG. 8.-A. Mammary gland. B. Mammary tumour (MMCIA). c. Anti-mammary gland
serum. D. Anti-mammary tumour (MMC1A) serum.
FIG. 9.-A. Anti-mammary tumour (MMCIA) serum. B. MMC1A (10 mg./ml.). c. MMC1A
(5 mg./ml.). D. MMC1A (2.5 mg./ml.). E. MMC1A (1.25 mg./ml.). F. MMC1A (0*62 mg./
ml.). G. MMC1A (0-31 mg./ml.).
FIG. 10.-A. Anti-mammary tumour (MMCIA) serum. B. MMC1A (10 mg./ml.). c. Urine
of a male RIII mouse, bearing MMC1A 18 days after grafting, tumour size 3-2 x 2-2 cm.
D. Urine of the same mouse as in c, 12 days after grafting, tumour size 2-7 x 1-6 cm.
E. Urine of a normal male RIII mouse.
FIG. 11.-A. Anti-mammary tumour (MMCIA) serum. B. MMC1A (10 mg./ml.). c. Urine
of a male RIII mouse, bearing MMC1A, 16 days after grafting, tumour size 3- 6 x 2- 6 cm.
D. Urine of a female RIII mouse, bearing MMC1A, 16 days after grafting, tumour size
3-2 x 2-4 cm. E. Urine of the same mouse as in c, 20 days after grafting, tumour size
3-9 x 2-8 cm. F. Urine of the same mouse as in D, 20 days after grafting tumour size
3-5 x 2-5 cm. G. Urine of a normal female RIII mouse.
FIG. 12.-A. Anti-mammary tumour (MMC1A) serum. B. MMC1A (10 mg./ml.). c. Urine of
a female C3H mouse bearing a spontaneous mammary tumour, size 1-3 x 1-2 cm.
D. Urine of a female C3H mouse bearing spontaneous mammary tumour, size 2-3 x
1-8 cm. E. Urine of a normal female C3H mouse. F. Empty.BRITISH JOURNAL OF CANCER.
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antisera, we observed that while three bands were produced by common antigens,
two or more bands definitely crossed (Fig. 7). The absorption with normal
tissue antigens by the addition of theii extracts to the dish resulted in the pro-
duction oftwo distinctly crossed bands and one straight band Thus two different
antigens were demonstrated in mammary tumours and mammary glands, both
absent in other normal tissues in equal concentrations, and also one antigen
common to mammary glands and mammary tumours, but not present in other
normal tissues (Fig. 8).
It is interesting to note that the first two bands oflow density, seen nextto the
antigen well (Fig. 9) were also produced by tumour extracts but not by normal
tissue extracts when used at concentrations of 10-20 mg./ml. The position of
these bands was also followed up in the titration experiments and it could be
shown that while the 2'5 mg./ml. extracts of mammary tumours could produce
these 2 bands, not less than 40 mg./ml. extracts of liver or kidney from normal
mice were required to produce similar bands. These antigens could not be
detected in extracts of spleen and lymph glands even at such high concentrations
as 40-80 mg./ml.
Apparently, though the actual concentrations of these antigens in tumours
and in normal tissues are lower than those of the antigen producing the con-
spicuous band, their concentration in tumour is still approximately 16 times higher
than in the normal tissues. Both antigens were destroyed by trypsin and by
boiling, and appeared in the soluble fraction after treatment with Rivanol.
Globulin in urines of tumour-bearing mice
The investigation on the presence of the antigen producing the strong MMCIA
band, in the urines of mice bearing the transplantable MMC1A ma-mmarv carcino-
ma, was started 8 days after grafting and continued up to the death of the mouse.
The urines were collected every 4-6 days from the same individual mice, or-
in some experiments-pooled from 2-4 mice with tumours of the same passage.
In the latter case, the urines of males and females were pooled separately. The
tumours were measured before collecting the urines. Urines of normal male and
female mice were collected at the same time and tested in the same petri dishes.
The antigens of the urines were tested against anti-MMClA sera and compared
with those of the MMC1A extracts.
The purpose of some experiments was to compare urines of males and females
taken at the same period; in others the urines ofeither males or females collected
at different periods, were compared.
Urines of mice with spontaneous RIII or C3H tumours of various sizes were
also investigated and compared with the urines of normal mice from the corres-
ponding strain.
It was shown that urine taken 8 days after grafting, did not produce a visible
MMC1A band, but 12 days after grafting a clear band appeared, identical with the
MMC1A band, and 4-6 days later, when the average tumour size reached 3-4
x 2 5 cm., a rather strong band was invariably observed (Fig. 10, 11). In urines
obtained after this period the density of the band did not increase and in some
cases was even reduced. There was no definite difference in the density and posi-
tion of this urinary band in males and females, though individual differences
were sometimes observed.
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The urines of mice with spontaneous mammary tumours produced in some
cases a weak band when the tumour was scarcely palpable, while a strong band
was invariably observed when tumours approached the average size of 2T3 x 1-8
cm. (Fig. 12). When the tumour grew further, the density of the line produced
by urine did not change for at least 3 weeks and then grew weaker though it was
still clear, up to the death of the animal. It should be noted, however, that at
this stage, though the tumours were actually large, their size was accounted for
by large necrotic masses and interstitial fluid.
No trace of the MMVCIA band was ever observed when urines of normal C3H
mice were tested. Tests with normal RIII mice indicated in 3 out of 20 urines
a weak band appearing in the same plates, where the urines of tumour bearing
mice produced strong bands.
It is interesting to note that besides the characteristic tumour band, another
weaker band, nearer to the serum well, was produced by the urines of tumour-
bearing and of normal mice. This band was also obtained from the extracts of
tumours as well as of normal tissues.
The antigens producing both urinary bands were destroyed by boiling and
remained in the soluble fraction after treatment with Rivanol, indicating that
two globulins were excreted in mouse urine, one ofthem predominantly by tumour-
bearing and the other also by normal mice.
A further test of mammary tumour extracts against the anti-tumour and the
anti-urine sera carried out simultaneously, revealed that 2 identical bands appear-
ed with both antisera. Thus the tumour and the urine of tumour-bearing mice
elicited two immunologically identical antibodies.
DISCUSSION
The first part of this study indicates the presence of an organ specific antigen
in the rrmammary glands, which is lacking in the mammary tumours. This
finding is similar to those of Weiler (1956) and Nairn et al. (1960). However, it
seems yet premature to draw any conclusions as to its relation to the process of
carcinogenesis.
The second part shows a considerable increase of an antigen in the mammary
tumours as compared to the homologous and other normal tissues. Both anti-
gens behaved like serum globulins, but were shown to be immunologically different.
More will be known on the position of these antigens among the globulin
fractions and on their similarity with serum globulins, after the completion of
immunoelectrophoretic studies now in progress. However, the work of Korngold
and van Leeuven (1957) with purified serum proteins permits their tentative
identification by the Ouchterlony method. It was shown that the gamma-
globulin produced a completely straight band, such as was obtained from the
specific mammary glands antigen (Fig. 1, 3); whereas antigens with smaller
molecular weight produced bands curved to the serum container, such as pro-
duced by the tumour antigen (Fig. 5, 9). Furthermore, Korngold has also shown
that the gamma-globulins are weaker antigens than the alpha- and beta-globulins
which could be analogous with the characteristics of the weak mammary gland
antigen and the strong tumour antigen. The latter produced an identity band
with that of an antigen shown to increase 4-8 times in serum of tumour-bearing
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animals. The same antigen was also shown to be present in organs of tumour-
bearing mice in a concentration 4 times higher than in the organs of normal mice.
The increase of this and another two, weaker antigens in the organs of tumour-
bearing animals cannot be explained by hypervolaemia, since the blood volume
ofliver and kidney is known to increase to only about 30 per cent, while a decrease
occurs in the blood space of spleen of tumour-bearing, as compared to normal
mice (Greenstein, 1954). This increase in liver and kidney can rather be explained
by the higher amount of the antigen in the serum, while an increase in the lymph
glands is more plausibly due to the increase ofthe antigen in the lymph, though it
may also be duie to an entirely different mechanism.
An immunologically identical globulin fraction was also found to be excreted
in urines of tumour-bearing mice.
Through quantitative and qualitative changes in the soluble antigens of malig-
nant tissues were repeatedly reported, little information is available (Mann and
Welker, 1940) on the possible similarity of changes in tissue proteins and those
known to occur in the spectrum of serum proteins of cancer patients and tumour-
bearing animals.
The decrease in albumins, as well as quantitative and qualitative changes in
the serum globulin fractions were repeatedly revealed by Ouchterlony gel pre-
cipitation and immunoelectrophoresis. Thus, Darcy (1957, 1960) demonstrated
that an alpha-globulin increased in plasma ofrats with transplantable and induced
tumours, as well as in sera of pregnant rats and those with regenerating liver; the
increase being apparently due to growth processes. Bernfeld et at. have found
an abnormal alpha globulin and quantitative changes in other alpha and gamma
globulin fractions in sera of mice with transplantable (Bernfeld and Homburger,
1955) and spontaneous tumours (Miller and Bernfeld, 1960) as well as similar
alterations in sera of patients with lung carcinoma (Bernfeld and Miller, 1960).
Clausen et al. (1959, 1960) and Rask-Nielsen, Gormsen and Clausen (1959) de-
monstrated a marked increase ofthe beta 2 III fraction in sera ofmice with leukae-
mia and with spontaneous or transplantable tumours, while an increase in the
beta 2 I fragtion and decrease ofgamma globulin was observed in sera ofmice with
hepatoma. The increase of the beta fra-Ition was explained as an immunological
response to tumour proteins.-Reviewing numerous data on tumour antigens,
Zilber (1958) suggested that " carcinogenesis involves first of all a disturbance
of globulin synthe3is ".
The present study revealed a similarity in the behaviour of tumour and serum
globulins, since a protein found in high amounts in tumours produced an identity
band with an antigen which was found also in increased amounts in sera, andwhich
also appeared in urines of tumour-bearing mice. This protein was probably not
related to that found by Darcy, since it was not present in embryos and did not
increase in sera of preanant mice. It is more likely to resemble the increasing
serum globulin fractions, described by Rask-Nielsen et al. (1959).
At the present stage of research, however, there is no convincing evidence on
the role and origin of this globulin. It may be produced and released by the
tumour cells, or it may occur in abnormal amounts at another location, as a result
of a disturbance in globulin synthesis, caused by tumour-growth, and subsequently
be selectively absorbed by the tumour. It may possibly be an immunological
response to tumour antigens.
It is also not known whether there is a causative relationship between the
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disappearance of a specific organ antigen and the increase of another protein in
the tumour of this organ, or are these only two parallel processes.
The antigen may be similar to that found in RIII mice by Plescia et al. (1959),.
but the possibility of its viral origin has still to be investigated.
These speculations all need experimental evidence and can only indicate wavs
for further research.
S1TMrNMARY
A specific tissue antigeni ofglobulin nature was denmonstrated in the mammary-
glands of the RIII mice. This antigen was lacking in the mammary tumours
of mice of the same strain.
An immunologically different antigen of globulin nature was demonstrated
in spontaneous and transplanted mammary tumours of mice of the same strain
in a concentration at least 30 times higher than in several tissues of normal mice.
This antigen was found in normal tissues and serum oftumour-bearing animals
in a concentration 4 times higher than in the corresponding tissues of normal
mice.
An immunologically identical globulin was shown to be present in considerable-
amounts in the urines of mice bearing spontaneous and transplantable mammarv
tumours.
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